Specifically, recombinant human PlGF supplementation restores the imbalance and abolished hypertension and GFR impairment in a rat preeclampsia model induced by reduced uterine perfusion pressure (RUPP) (Spradley et al., 2016). This evidence concerns the gene PGF and hypertensive disorder.